Creative Medical Technology Holdings (CELZ) PE Ratio: History & Chart

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T16:21:33.676Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:21:33.676Z.

Quote observation: 2026-10-06T16:18:27.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 0.8981
Unrounded diluted TTM EPS · period ending 2026-06-30: -2

FMP input reference: 1e75b902c2fc2180dd85d0e717aea95d739fa4c46657779fc742098741b775f2

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

CELZ PE Ratio Metrics

PE RATIO

N/A

CELZ Competitors' PE Ratio

CELZ

Creative Medical Technology Holdings, Inc.

Current

Market Cap

$2.32M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ONCO

Onconetix, Inc.

vs CELZ

Market Cap

$2.38M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GOVX

GeoVax Labs, Inc.

vs CELZ

Market Cap

$2.25M

PE Ratio

N/A

TTM Avg

98120994617.14

3Y Avg

98120994617.14

5Y Avg

98120994617.14

MBRX

Moleculin Biotech, Inc.

vs CELZ

Market Cap

$2.43M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BIAF

bioAffinity Technologies, Inc.

vs CELZ

Market Cap

$2.51M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FBLG

FibroBiologics, Inc. Common Stock

vs CELZ

Market Cap

$2.52M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

JAGX

Jaguar Health, Inc.

vs CELZ

Market Cap

$2.56M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NUWE

Nuwellis, Inc.

vs CELZ

Market Cap

$2.62M

PE Ratio

N/A

TTM Avg

0.58

3Y Avg

0.58

5Y Avg

0.58

ISPC

iSpecimen Inc.

vs CELZ

Market Cap

$2.63M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AMIX

Autonomix Medical, Inc.

vs CELZ

Market Cap

$1.93M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Creative Medical Technology Holdings, Inc. (CELZ)	$2.32M	N/A	N/A	N/A	N/A
Onconetix, Inc. (ONCO)vs ›	$2.38M	N/A	N/A	N/A	N/A
GeoVax Labs, Inc. (GOVX)vs ›	$2.25M	N/A	98120994617.14	98120994617.14	98120994617.14
Moleculin Biotech, Inc. (MBRX)vs ›	$2.43M	N/A	N/A	N/A	N/A
bioAffinity Technologies, Inc. (BIAF)vs ›	$2.51M	N/A	N/A	N/A	N/A
FibroBiologics, Inc. Common Stock (FBLG)vs ›	$2.52M	N/A	N/A	N/A	N/A
Jaguar Health, Inc. (JAGX)vs ›	$2.56M	N/A	N/A	N/A	N/A
Nuwellis, Inc. (NUWE)vs ›	$2.62M	N/A	0.58	0.58	0.58
iSpecimen Inc. (ISPC)vs ›	$2.63M	N/A	N/A	N/A	N/A
Autonomix Medical, Inc. (AMIX)vs ›	$1.93M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$0.90

÷

Forward EPS (Est.)

$-1.18

=

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

CELZ PE Ratio Metrics

CELZ Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics